Wells Fargo’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.6K Buy
5,833
+878
+18% +$9.12K ﹤0.01% 5031
2025
Q1
$65.3K Buy
4,955
+108
+2% +$1.42K ﹤0.01% 4853
2024
Q4
$86.8K Buy
4,847
+2,568
+113% +$46K ﹤0.01% 4785
2024
Q3
$36.7K Sell
2,279
-88
-4% -$1.42K ﹤0.01% 5058
2024
Q2
$63.9K Buy
2,367
+1,025
+76% +$27.7K ﹤0.01% 4828
2024
Q1
$26.2K Buy
1,342
+169
+14% +$3.3K ﹤0.01% 5111
2023
Q4
$24.3K Buy
1,173
+246
+27% +$5.09K ﹤0.01% 5130
2023
Q3
$29.5K Sell
927
-603
-39% -$19.2K ﹤0.01% 5078
2023
Q2
$51.4K Buy
1,530
+1,484
+3,226% +$49.9K ﹤0.01% 5137
2023
Q1
$1.9K Buy
46
+20
+77% +$827 ﹤0.01% 5911
2022
Q4
$884 Buy
26
+1
+4% +$34 ﹤0.01% 5897
2022
Q3
$1K Sell
25
-3
-11% -$120 ﹤0.01% 6111
2022
Q2
$1K Sell
28
-3,035
-99% -$108K ﹤0.01% 6286
2022
Q1
$113K Sell
3,063
-834
-21% -$30.8K ﹤0.01% 4946
2021
Q4
$381K Sell
3,897
-763
-16% -$74.6K ﹤0.01% 4550
2021
Q3
$581K Buy
4,660
+2,832
+155% +$353K ﹤0.01% 4330
2021
Q2
$229K Buy
1,828
+1,061
+138% +$133K ﹤0.01% 4675
2021
Q1
$105K Sell
767
-3,085
-80% -$422K ﹤0.01% 5123
2020
Q4
$350K Sell
3,852
-1,454
-27% -$132K ﹤0.01% 4679
2020
Q3
$394K Buy
5,306
+1,111
+26% +$82.5K ﹤0.01% 4400
2020
Q2
$357K Buy
4,195
+4,189
+69,817% +$356K ﹤0.01% 4421
2020
Q1
$0 Buy
+6
New ﹤0.01% 6267
2019
Q3
Sell
-64
Closed -$4K 6130
2019
Q2
$4K Sell
64
-229
-78% -$14.3K ﹤0.01% 5652
2019
Q1
$21K Sell
293
-1
-0.3% -$72 ﹤0.01% 5418
2018
Q4
$23K Sell
294
-503
-63% -$39.4K ﹤0.01% 5408
2018
Q3
$372K Buy
797
+3
+0.4% +$1.4K ﹤0.01% 4510
2018
Q2
$316K Buy
794
+46
+6% +$18.3K ﹤0.01% 4628
2018
Q1
$229K Sell
748
-35
-4% -$10.7K ﹤0.01% 4730
2017
Q4
$230K Buy
783
+436
+126% +$128K ﹤0.01% 4725
2017
Q3
$190K Buy
347
+174
+101% +$95.3K ﹤0.01% 4779
2017
Q2
$103K Hold
173
﹤0.01% 4945
2017
Q1
$74K Hold
173
﹤0.01% 5058
2016
Q4
$89K Buy
+173
New +$89K ﹤0.01% 4974